ABVD vs. COPPEBVCAD (CEC) vs. BEACOPP for the initial treatment of patients with advanced Hodgkin lymphoma(HL). Preliminary results of HD2000 GISL trial

被引：0
|
作者：
Federico, M. [1 ]
Luminari, S. [1 ]
Olio, M. Dell' [2 ]
Merli, F. [3 ]
Brugiatelli, M. [4 ]
Stelitano, C. [5 ]
Mammi, C. [1 ]
Musso, M. [6 ]
Baldini, L. [7 ]
Marcheselli, L. [1 ]
Gobbi P G, P. G. [8 ]
机构：
[1] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[2] AO Casa Sollievo Sofferenza, San Giovanni Rotondo, FG, Italy
[3] AOS Maria Nuova, Reggio Emilia, Italy
[4] AO Papardo, Messina, Italy
[5] AO Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[6] AO La Maddalena, Palermo, Italy
[7] Osped Maggiore, IRCCS, Milan, Italy
[8] Univ Pavia, Med Clin, I-27100 Pavia, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [11] Cognitive-behavioral rehabilitation vs. treatment as usual for bipolar patients preliminary results
    Gomes, B. C.
    Rocca, C. C. D. A.
    Belizario, G. O.
    Lafer, B.
    BIPOLAR DISORDERS, 2018, 20 : 134 - 134
  • [12] THE UTILITY OF END OF TREATMENT FDG-PET SCANNING IN PAEDIATRIC AND ADOLESCENT HODGKIN LYMPHOMA: THE UK EXPERIENCE OF PATIENTS IN THE HD2000 02 TRIAL
    Daw, S.
    Hayward, J.
    Shankar, A.
    Wallace, W. H.
    Hewitt, M.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 881 - 881
  • [13] A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma
    Pangalis, GA
    Vassilakopoulos, TP
    Michalis, E
    Roussou, P
    Vrakidou, E
    Repousis, P
    Angelopoulou, MK
    Siakantaris, MP
    Korantzis, J
    Symeonidis, A
    Grigorakis, V
    Stefanoudakis, E
    Stamatellou, M
    Bourantas, KL
    Kalmantis, T
    Christopoulos, G
    Kokkinis, G
    Mihalakeas, I
    Papayiannis, A
    LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 635 - 644
  • [14] BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S LYMPHOMA FROM POOR-PROGNOSIS GROUP: PRELIMINARY RESULTS OF PROSPECTIVE RANDOMIZED MULTYCENTER STUDY
    Kriachok, I.
    Titorenko, I.
    Filonenko, K.
    Aleksik, E.
    Novosad, O.
    Kadnikova, T.
    Kushchevoy, E.
    Martinchik, A.
    Pastushenko, Y.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 550 - 550
  • [15] DOSE-ESCALATION WITH BEACOPP ESCALATED IS SUPERIOR TO ABVD IN THE COMBINED-MODALITY TREATMENT OF EARLY UNFAVORABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD14 TRIAL
    Borchmann, P.
    Diehl, V.
    Pluetschow, A.
    Von Tresckow, B.
    Markova, J.
    Hitz, F.
    Kra, Z.
    Greil, R.
    Topp, M. S.
    Villalobos, M.
    Zijlstra, J. M.
    Soekler, M.
    Fuchs, M.
    Engert, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 180 - 180
  • [16] Preliminary results of a phase III trial of hormonal therapy vs. chemohormonal therapy as initial treatment for non-localized prostate cancer
    Millikan, RE
    Brown, M
    Moomey, B
    Logothetis, CJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 384 - 384
  • [17] BEACOPP-14 Vs. BEACOPP-esc in Patients With Hodgkin's Disease From Poor-prognosis Group - Updated Results of Prospective Randomized Multicenter Study
    Titorenko, I.
    Kriachok, I.
    Filonenko, K.
    Novosad, O.
    Alexik, O.
    Kadnikova, T.
    Martynchik, A.
    Kadnikova, T.
    Kuscshevyy, E.
    Pastushenko, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S648 - S648
  • [18] A randomised controlled trial of ABVD vs two multi-drug regimens for advanced Hodgkin lymphoma - Updated results of UKLG LY09
    Radford, JA
    Cullen, MH
    Hancock, BW
    Walewski, J
    Sydes, MR
    Ryder, D
    Smith, P
    Clawson, S
    Stenning, SP
    Johnson, PWM
    ANNALS OF ONCOLOGY, 2005, 16 : 51 - 51
  • [19] Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease.
    Straus, DJ
    Yahalom, J
    Zelenetz, AD
    Qin, J
    Myers, J
    Moskowitz, CH
    Noy, A
    Bertino, JR
    Portlock, CS
    BLOOD, 2001, 98 (11) : 769A - 769A
  • [20] Stanford V (SV) regimen versus ABVD for the treatment of advanced Hodgkin lymphoma (HL): Results of a UKNCRI/LTO randomised phase II trial.
    Johnson, P
    Hoskin, P
    Horwich, A
    Hancock, B
    Smith, P
    Stevens, L
    Qian, W
    Sweetenham, JW
    BLOOD, 2004, 104 (11) : 93A - 93A
12345